Takeda Chemical Industries Ltd. | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $22,000,000 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | benefit plan administrator violation | 2023 | private lawsuit-federal | $22,000,000 |
GlaxoSmithKline PLC | GSK plc | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $21,500,000 |
Johnson & Johnson | Johnson & Johnson | Foreign Corrupt Practices Act | 2011 | DOJ_CRIMINAL | $21,400,000 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2023 | TX-AG | $21,350,000 |
Schering-Plough Corporation | Merck | price-fixing or anti-competitive practices | 2009 | CA-AG | $21,300,000 |
Novartis Pharmaceuticals | Novartis | False Claims Act and related | 2019 | IL-AG | $21,280,356 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2002 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $21,084,700 |
Alexion Pharmaceuticals Inc. | AstraZeneca | Foreign Corrupt Practices Act | 2020 | SEC | $21,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | RI-AG | $21,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,786,034 |
DUSA Pharmaceuticals, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $20,750,000 |
Celgene Corp. | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000 |
GlaxoSmithKline plc | GSK plc | kickbacks and bribery | 2016 | SEC | $20,000,000 |
Jazz Pharmaceuticals Inc. | Jazz Pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | USAO | $20,000,000 |
Clovis Oncology Inc. | Clovis Oncology | investor protection violation | 2018 | SEC | $20,000,000 |
Eli Lilly | Eli Lilly | off-label or unapproved promotion of medical products | 2010 | LA-AG | $20,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
Impax Laboratories, Inc. | Amneal Pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $20,000,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $19,900,000 |
Sanofi-Pasteur | Sanofi | False Claims Act and related | 2017 | DOJ_CIVIL | $19,868,194 |
Merck | Merck | water pollution violation | 2007 | EPA | $19,750,000 |
Pharmacia & Upjohn Company Inc. | Pfizer | kickbacks and bribery | 2007 | USAO | $19,700,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2016 | MULTI-AG | $19,500,000 |
Purdue Pharma | Purdue Pharma | off-label or unapproved promotion of medical products | 2007 | MULTI-AG | $19,500,000 |
Genentech Inc. | Roche | off-label or unapproved promotion of medical products | 2000 | MULTI-AG | $19,000,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $19,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $19,000,000 |
Pharmacia Corporation | Pfizer | False Claims Act and related | 2019 | IL-AG | $18,960,210 |
Wyeth LLC | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $18,876,624 |
Dey, Inc. | Viatris | False Claims Act and related | 2003 | DOJ_CIVIL | $18,500,000 |
Eli Lilly | Eli Lilly | off-label or unapproved promotion of medical products | 2010 | AR-AG | $18,500,000 |
Eli Lilly | Eli Lilly | off-label or unapproved promotion of medical products | 2010 | MS-AG | $18,500,000 |
Endo Pharmaceuticals | Endo International | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Acclarent Inc. | Johnson & Johnson | False Claims Act and related | 2016 | DOJ_CIVIL | $18,000,000 |
Ranbaxy Pharmaceuticals, Inc. et al. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $17,875,000 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
Bausch & Lomb | Bausch Health | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $17,500,000 |
Sun Pharmaceuticals Industries Ltd | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $17,357,000 |
Solvay Pharmaceuticals Inc. | AbbVie | consumer protection violation | 2010 | private lawsuit-federal | $16,500,000 |
St. Jude Medical Inc. | Abbott Laboratories | kickbacks and bribery | 2011 | DOJ_CIVIL | $16,000,000 |
Sandoz | Sandoz Group | False Claims Act and related | 2009 | KY-AG | $16,000,000 |
Purdue Pharma L.P. | Purdue Pharma | price-fixing or anti-competitive practices | 2010 | private lawsuit-federal | $16,000,000 |
Endo Health Solutions Inc. | Endo International | product safety violation | 2017 | private lawsuit-federal | $15,500,000 |
Mallinckrodt ARD LLC | Mallinckrodt | kickbacks and bribery | 2019 | DOJ_CIVIL | $15,400,000 |
Sanofi-Aventis U.S. LLC | Sanofi | employment discrimination | 2010 | private lawsuit-federal | $15,360,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
Geneva Pharmaceuticals | Novartis | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2013 | MA-AG | $15,100,000 |
Pfizer H.C.P. Corporation | Pfizer | Foreign Corrupt Practices Act | 2012 | DOJ_CRIMINAL | $15,000,000 |
Elan Corporation, plc | Perrigo | accounting fraud or deficiencies | 2005 | SEC | $15,000,000 |
Allergan Inc. | AbbVie | investor protection violation | 2017 | SEC | $15,000,000 |
Pharmacia & Upjohn Company LLC | Pfizer | kickbacks and bribery | 2007 | USAO | $15,000,000 |
GlaxoSmithKline, LLC | GSK plc | off-label or unapproved promotion of medical products | 2013 | MD-AG | $15,000,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2005 | private lawsuit-federal | $15,000,000 |
Allergan | AbbVie | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $15,000,000 |
Impax Laboratories, Inc. | Amneal Pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $15,000,000 |
Elanco Animal Health Inc. | Elanco Animal Health | accounting fraud or deficiencies | 2024 | SEC | $15,000,000 |
Elanco Animal Health Inc. | Elanco Animal Health | product safety violation | 2025 | private lawsuit-federal | $15,000,000 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Aventis Pharmaceutical L.P. | Sanofi | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Forest Laboratories | AbbVie | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Shering-Plough/Warrick Companies | Merck | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Allergan Inc. | AbbVie | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $14,750,000 |
Shire US Inc. | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $14,750,000 |
Aventis Pharmaceuticals | Sanofi | False Claims Act and related | 2019 | IL-AG | $14,708,388 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2011 | FDA | $14,500,000 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $14,377,600 |
Bristol-Myers Squibb | Bristol-Myers Squibb | Foreign Corrupt Practices Act | 2015 | SEC | $14,000,000 |
Merck KgaA | Merck KGaA (EMD) | price-fixing or anti-competitive practices | 2000 | DOJ_ANTITRUST | $14,000,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | DOJ_CIVIL | $14,000,000 |
GlaxoSmithKline | GSK plc | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
Glenmark Pharmaceuticals | Glenmark Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $14,000,000 |
Glenmark Generics Inc. | Glenmark Pharmaceuticals | False Claims Act and related | 2015 | TX-AG | $13,750,000 |
Abbott Laboratories | Abbott Laboratories | False Claims Act and related | 2019 | IL-AG | $13,747,929 |
AbbVie Inc. | AbbVie | False Claims Act and related | 2019 | IL-AG | $13,747,929 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | $13,500,000 |
Allergan, Inc. | AbbVie | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $13,450,000 |
Astellas Pharma US, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $13,250,000 |
Sandoz | Sandoz Group | False Claims Act and related | 2013 | LA-AG | $13,100,000 |
Alere Inc. | Abbott Laboratories | accounting fraud or deficiencies | 2017 | SEC | $13,023,885 |
Alexion Pharmaceuticals Inc. | AstraZeneca | False Claims Act and related | 2019 | DOJ_CIVIL | $13,000,000 |
Eli Lilly and Co. | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | ID-AG | $13,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $13,000,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $13,000,000 |
Allergan Inc. | AbbVie | False Claims Act and related | 2017 | private lawsuit-federal | $13,000,000 |
Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | False Claims Act and related | 2022 | TX-AG | $12,900,000 |
Sandoz, Inc. | Sandoz Group | HHS civil monetary penalties | 2015 | HHSOIG | $12,640,000 |
Incyte Corporation | Incyte Corp. | False Claims Act and related | 2021 | DOJ_CIVIL | $12,600,000 |
Schering-Plough Corporation | Merck | benefit plan administrator violation | 2012 | private lawsuit-federal | $12,250,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | kickbacks and bribery | 2014 | IL-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000 |
SciClone Pharmaceuticals | SciClone Pharmaceuticals | Foreign Corrupt Practices Act | 2016 | SEC | $12,000,000 |
Hoechst AG | Sanofi | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
Sanofi-Aventis U.S., LLC | Sanofi | False Claims Act and related | 2020 | USAO | $11,850,000 |
Novartis Pharmaceuticals Corporation | Novartis | kickbacks and bribery | 2020 | CA-AG | $11,800,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,750,000 |
Watson/Schein Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2011 | TX-AG | $11,300,000 |
Eisai Inc. | Eisai | off-label or unapproved promotion of medical products | 2010 | FDA | $11,000,000 |